INOVIO PHARMACEUTICALS, INC. Warrants and Rights Outstanding
INOVIO PHARMACEUTICALS, INC. (INO) had Warrants and Rights Outstanding of $25.02 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:WarrantsAndRightsOutstanding · last filed 2026-08-12
- 2026-06-30: Warrants and Rights Outstanding $25.02M.
- 2026-03-31: Warrants and Rights Outstanding $24.93M.
- 2025-12-31: Warrants and Rights Outstanding $29.07M.
- 2025-09-30: Warrants and Rights Outstanding $50.38M.
| Period end | Warrants and Rights Outstanding |
|---|---|
| 2026-06-30 | $25.02M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $24.93M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $29.07M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $50.38M 10-Q · filed 2025-11-10 |
| 2024-12-31 | $13.26M 10-K · filed 2026-03-12 |
| 2018-12-31 | $0.00 10-K · filed 2019-03-12 |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-08 |
| 2018-06-30 | $228.66K 10-Q · filed 2018-08-07 |
| 2018-03-31 | $488.64K 10-Q · filed 2018-05-09 |
| 2017-12-31 | $360.80K 10-K · filed 2019-03-12 |
| 2017-09-30 | $940.34K 10-Q · filed 2017-11-08 |
| 2017-06-30 | $1.36M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $1.05M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $1.17M 10-K · filed 2018-03-14 |
| 2016-09-30 | $1.81M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $1.82M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $1.71M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $1.30M 10-K · filed 2017-03-15 |
| 2015-09-30 | $1.09M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $1.71M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $1.73M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $2.02M 10-K · filed 2016-03-14 |
| 2014-09-30 | $2.21M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $3.11M 10-Q · filed 2014-08-11 |
| 2014-03-31 | $6.05M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $19.54M 10-K · filed 2015-03-16 |
| 2013-09-30 | $14.10M 10-Q · filed 2013-11-12 |
| 2013-06-30 | $13.45M 10-Q · filed 2013-08-09 |
| 2013-03-31 | $10.25M 10-Q · filed 2013-05-10 |
| 2012-12-31 | $2.86M 10-K · filed 2014-03-17 |
| 2012-09-30 | $6.16M 10-Q · filed 2012-11-07 |
| 2012-06-30 | $5.04M 10-Q · filed 2012-08-09 |
| 2012-03-31 | $8.42M 10-Q · filed 2012-05-09 |
| 2011-12-31 | $5.18M 10-K · filed 2013-03-18 |
| 2011-09-30 | $4.52M 10-Q · filed 2011-11-07 |
| 2011-06-30 | $4.87M 10-Q · filed 2011-08-05 |
| 2010-12-31 | $370.93K 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |